Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.
Neurogenic detrusor overactivity: an update on management options.
Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells.
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
Identifying Symptom Co-Occurrence in Persons With Multiple Sclerosis.
Risperidone-Induced Pisa Syndrome in MS: Resolution with Lurasidone and Recurrence with Chlorpromazine.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
A Further TWEAK to Multiple Sclerosis Pathophysiology.
Baló's concentric sclerosis: imaging findings and pathological correlation.
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.
Vitamin D in allergic disorders.
Change in perceived health insurance coverage among people with multiple sclerosis.
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
High variability of fabry disease manifestations in an extended italian family.
A specific vaccine to protect patients with multiple sclerosis from herpes zoster.
Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic.
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis.
Vitamin D3 Induces IDO(+) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE.
Intractable Vomiting Antecedent to Optic Neuritis: An Early Clinical Clue to Neuromyelitis Optica.
Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryo.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
Evolution of diagnostic criteria for multiple sclerosis.
Pages
« first
‹ previous
…
484
485
486
487
488
489
490
491
492
…
next ›
last »